Journal of the American Academy of Child & Adolescent Psychiatry
New researchTrends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003–2011
Section snippets
Method
The NSCH is a national cross-sectional, random-digit–dialed telephone survey conducted in 2003 to 2004 (designated as “2003”), 2007 to 2008 (“2007”), and 2011–2012 (“2011”).24, 25, 30 The NSCH uses the sampling frame of the National Immunization Survey31; because of the rise in the prevalence of cell-phone–only households, the 2011 NSCH added a sample of cell-phone numbers. Between February 2011 and June 2012, 95,677 interviews were completed, resulting in landline and cell-phone interview
Results
All ADHD survey indicators extended from parent-reported data for children/adolescents aged 4 to 17 years; for brevity, the term “parent-reported” and age (4–17 years) is excluded as a qualifier of the relevant estimates that follow.
Discussion
The epidemiological profile for ADHD diagnosis and treatment continues to evolve. Based on parent-reported indicators of health care provider–diagnosed ADHD diagnosis and treatment, more than 1 in 10 school-aged children (11%) had received an ADHD diagnosis by a health care provider by 2011, representing more than 6.4 million children nationally. Nearly 1 in 5 high school boys and 1 in 11 high school girls had been diagnosed with ADHD. Of those with a history of ADHD, 83% had current ADHD in
References (57)
- et al.
Identified attention-deficit/hyperactivity disorder and medically attended, nonfatal injuries: US school-age children, 1997-2002
Ambul Pediatr
(2006) - et al.
Association of externalizing behavior disorder symptoms and injury among fifth graders
Acad Pediatr
(2011) - et al.
Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD
J Am Acad Child Adolesc Psychiatry
(2008) - et al.
Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010
Acad Pediatr
(2012) - et al.
Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)
J Am Acad Child Adolesc Psychiatry
(2010) - et al.
MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study
J Am Acad Child Adolesc Psychiatry
(2009) - et al.
Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey–Adolescent Supplement (NCS-A)
J Am Acad Child Adolesc Psychiatry
(2011) - et al.
Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD)
Neurosci Biobehav Rev
(2012) - et al.
Adolescent substance use in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication
J Am Acad Child Adolesc Psychiatry
(2013) - et al.
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007
J Am Acad Child Adolesc Psychiatry
(2010)
Trends in antipsychotic drug use by very young, privately insured children
J Am Acad Child Adolesc Psychiatry
Diagnostic and Statistical Manual of Mental Disorders. Fifth ed
Injuries to children with attention deficit hyperactivity disorder
Pediatrics
Children with attention deficit hyperactivity disorder and attendance at hospital
Eur J Emerg Med
Attention deficit hyperactivity disorder and increased risk of injury
Adv Med Sci
Academic and educational outcomes of children with ADHD
J Pediatr Psychol
Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study
Pediatrics
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder
J Am Acad Child Adolesc Psychiatry
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents
Pediatrics
A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder
Arch Gen Psychiatry
National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder
Pediatrics
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder
J Clin Child Adolesc Psychol
Attention deficit hyperactivity disorder: effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment
ADHD drugs and serious cardiovascular events in children and young adults
N Engl J Med
Sudden death and use of stimulant medications in youths
Am J Psychiatry
Recent trends in childhood attention-deficit/hyperactivity disorder
JAMA Pediatr
Cited by (0)
This article is discussed in an editorial by Dr. John T. Walkup on page 14.
Clinical guidance is available at the end of this article.
An interview with the authors is available by podcast at www.jaacap.org or by scanning the QR code to the right.
Ms. Danielson served as the statistical expert for this research.
Disclaimer: The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
The National Survey of Children’s Health is a module of the Centers for Disease Control and Prevention’s State and Local Area Integrated Telephone Survey and was sponsored by the Maternal and Child Health Bureau of the Health Resources and Services Administration.
Disclosure: Drs. Bitsko, Holbrook, Kogan, Ghandour, Perou, and Blumberg, and Ms. Visser and Ms. Danielson report no biomedical financial interests or potential conflicts of interest.